Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm, Exploratory, Phase II Clinical Study of the Efficacy and Safety of Trastuzumab (T-DXd) in Combination With Pyrotinib in Patients Progressed After T-DXd Treatment for Advanced HER2-positive Breast Cancer

NCT07836257 is registered in ClinicalTrials.gov with Fujian Medical University as lead sponsor.

NCT NCT07836257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07836257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm, Exploratory, Phase II Clinical Study of the Efficacy and Safety of Trastuzumab (T-DXd) in Combination With Pyrotinib in Patients Progressed After T-DXd Treatment for Advanced HER2-positive Breast Cancer
Lead sponsor
Fujian Medical University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 10, 2026
Completion date
October 30, 2029
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer